While impressive that 63% of patients lost greater than 5% of their weight over the course of 56 weeks in this trial, liraglutide 3.0's prescribing information recommends that it be discontinued at 16 weeks if the patient has not lost 4% or more body weight. In this trial, what percentage of subjects taking the medication at 16 weeks had lost 4% of their weight? (Hard to interpret this from Figure 1A). What was the evidence that supported inclusion of this 4% cutoff in the prescribing instructions?
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.